Dr. Bilal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1501 N Campbell Ave
Rm 8339
Tucson, AZ 85724Phone+1 520-626-4111Fax+1 520-626-4171
Summary
- Jawad Bilal, MD, is a rheumatologist based in Tucson, AZ. He completed his residency in Internal Medicine from 2014 to 2017 and a fellowship in Rheumatology from 2018 to 2020, both at the University of Arizona College of Medicine-Tucson. He graduated from Nishtar Medical College in 2012. Dr. Bilal has several publications to his name, including studies on tanezumab for osteoarthritis pain and Janus kinase inhibitors' risk of venous thromboembolism, with some of his work being cited in other publications multiple times.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Rheumatology, 2018 - 2020- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2014 - 2017
Nishtar Medical CollegeClass of 2012
Certifications & Licensure
AZ State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 6 citationsTanezumab for the treatment of osteoarthritis pain.Farva R Gondal, Jawad Bilal, C Kent Kwoh
Drugs of Today. 2022-04-01 - Recurrent strokes and memory loss in a patient with triple-positive antiphospholipid antibody syndrome.Chinenye Osuorji, Jawad Bilal, Ikenna Osuorji
BMJ Case Reports. 2022-03-25 - Lisinopril-Associated Recurrent Hemorrhagic Pancreatitis.Maryam Bushra Ahmed, Jawad Bilal
American Journal of Therapeutics. 2021-09-01
Journal Articles
- Psoriasis and Psoriatic Spectrum Disease: A Primer for the Primary Care PhysicianJawad Bilal, MD, The American Journal of Medicine
Press Mentions
Interleukin Inhibitors Linked with Higher Infection, Cancer RiskNovember 1st, 2019
Risk of Infections and Cancer in Patients with Rheumatologic Diseases Receiving Interleukin InhibitorsOctober 18th, 2019
With Back Pain, Depression Tied to Higher Healthcare Spending: StudyNovember 29th, 2018
Professional Memberships
- Member
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
